DLIN-MC4-DMA

CAS No. 1226909-66-5

DLIN-MC4-DMA( —— )

Catalog No. M37350 CAS No. 1226909-66-5

DLIN-MC4-DMA is a lipid membrane and is a potential nucleic acid carrier.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 53 Get Quote
5MG 75 Get Quote
10MG 123 Get Quote
25MG 242 Get Quote
50MG 410 Get Quote
100MG 620 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DLIN-MC4-DMA
  • Note
    Research use only, not for human use.
  • Brief Description
    DLIN-MC4-DMA is a lipid membrane and is a potential nucleic acid carrier.
  • Description
    DLin-M-C4-DMA (Compound MC4) is a cationic lipid. DLin-M-C4-DMA can be used for delivery of nucleic acids.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1226909-66-5
  • Formula Weight
    656.12
  • Molecular Formula
    C44H81NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OC(CCCCN(C)C)=O)(CCCCCCCC/C=C\C/C=C\CCCCC)CCCCCCCC/C=C\C/C=C\CCCCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Steven M. Ansell, et al. Lipids and lipid nanoparticle formulations for delivery of nucleic acids. Patent US10166298. 2019-01-01.
molnova catalog
related products
  • Podophyllotoxone

    Podophyllotoxinone a natural compound found in Dysosma versipellis shows inhibitory activity against L1210 leukemia and KB cells in vitro.

  • (R)-Elagolix

    (R)-Elagolix is a short-acting, nonpeptide, GnRH antagonist with an IC50 and Ki of 0.25 and 3.7 nM, respectively.?

  • Atezolizumab

    Atezolizumab anti-PD-L1) is a fully humanized IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1 but not the interaction of PD-L2 with PD-1.